Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$630M |
| 2 |
Nike
NKE
|
+$627M |
| 3 |
XYZ
Block Inc
XYZ
|
+$306M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$295M |
| 5 |
FedEx
FDX
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
Meta Platforms (Facebook)
META
|
+$669M |
| 3 |
AbbVie
ABBV
|
+$567M |
| 4 |
Corning
GLW
|
+$343M |
| 5 |
McDonald's
MCD
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Consumer Discretionary | 16.55% |
| 3 | Financials | 13.82% |
| 4 | Healthcare | 12.55% |
| 5 | Communication Services | 11.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Warrior Met Coal
HCC
$4.19B
| $15M | 0.01% |
535,517
-351,688
| -40% | -$10.2M |
|
427
Spyre Therapeutics
SYRE
$8.54B
| $14.9M | 0.01% |
60,204
+4,466
| +8% | +$807K |
|
428
Ocular Therapeutix
OCUL
$1.79B
| $14.9M | 0.01% |
2,292,752
+297,984
| +15% | +$1.68M |
|
429
Alcoa
AA
$11.9B
| $14.9M | 0.01% |
331,887
-222,798
| -40% | -$11M |
|
430
Constellium
CSTM
$3.76B
| $14.9M | 0.01% |
1,373,661
-425,738
| -24% | -$5.2M |
|
431
First Bancorp
FBNC
$2.6B
| $14.6M | 0.01% |
410,469
+317,529
| +342% | +$11.4M |
|
432
Range Resources
RRC
$9.38B
| $14.6M | 0.01% |
1,005,885
-74,862
| -7% | -$1.12M |
|
433
Freeport-McMoran
FCX
$90B
| $14.4M | 0.01% |
821,814
-293,878
| -26% | -$5.52M |
|
434
Acadia Healthcare
ACHC
$2.76B
| $14.1M | 0.01% |
360,971
-498,389
| -58% | -$18.3M |
|
|
NBLX
435
DELISTED
Noble Midstream Partners LP
NBLX
| $13.6M | 0.01% |
290,653
+8,185
| +3% | +$424K |
|
|
AIMT
436
DELISTED
Aimmune Therapeutics
AIMT
| $13.4M | 0.01% |
+421,866
| New | +$14.8M |
|
437
Kinder Morgan
KMI
$71.7B
| $13.3M | 0.01% |
883,136
+17,998
| +2% | +$312K |
|
438
Chemours
CC
$2.5B
| $13.1M | 0.01% |
269,454
-43,037
| -14% | -$2.15M |
|
|
FTSI
439
DELISTED
FTS International, Inc. Common Stock
FTSI
| $12.7M | 0.01% |
+34,443
| New | +$13.4M |
|
440
CALL
Bristol-Myers Squibb
BMY
$133B
| $12.7M | 0.01% |
200,000
+25,000
| +14% | +$1.61M |
|
|
DBD
441
DELISTED
Diebold Nixdorf Incorporated
DBD
| $12.6M | 0.01% |
818,207
-492,802
| -38% | -$8.23M |
|
442
Diageo
DEO
$49B
| $12.4M | 0.01% |
91,511
-27,873
| -23% | -$3.88M |
|
443
Huron Consulting
HURN
$2.41B
| $12.4M | 0.01% |
325,014
+84,253
| +35% | +$3.32M |
|
444
Philips
PHG
$25.7B
| $11.9M | 0.01% |
410,543
-135,774
| -25% | -$4.04M |
|
445
Cardlytics
CDLX
$21.7M
| $11.9M | 0.01% |
+81,129
| New | +$13.7M |
|
446
Nutrien
NTR
$33.2B
| $11.8M | 0.01% |
+248,807
| New | +$12.5M |
|
447
Eastman Chemical
EMN
$8B
| $11.5M | 0.01% |
108,880
-35,397
| -25% | -$3.58M |
|
|
AM
448
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
| $11.3M | 0.01% |
437,165
-1,228
| -0.3% | -$35K |
|
|
NUVA
449
DELISTED
NuVasive, Inc.
NUVA
| $10.9M | 0.01% |
208,038
+32,060
| +18% | +$1.63M |
|
|
SEI
450
Solaris Energy Infrastructure
SEI
$3.15B
| $10.6M | 0.01% |
639,218
-182,589
| -22% | -$3.44M |
|
Similar funds
Jennison Associates's Q1 2018 Portfolio in Review
As of Q1 2018, Jennison Associates held 730 positions worth $101B, down 0.67% from $101B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jennison Associates withdrew a net $4.02B in Q1 2018, closing 79 positions and reducing 339 holdings. Its most notable exit was Newell Brands, an estimated $95.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in Emerson Electric worth $113M.
- Jennison Associates's largest Q1 2018 buy was Emerson Electric: 1,658,090 shares worth $113M.
- Jennison Associates added most to PNC Financial Services in Q1 2018, an estimated $630M increase.
- Jennison Associates's biggest Q1 2018 reduction was Apple, cutting an estimated $1.2B.
- Jennison Associates fully exited Newell Brands in Q1 2018, selling an estimated $95.7M.
- Jennison Associates's ten largest holdings make up 28% of its $101B portfolio in Q1 2018.
- Jennison Associates opened 81 new positions and closed 79 in Q1 2018.
- Jennison Associates's portfolio value fell 0.67% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q1 2018, filed 20 Apr 2018.